antigen testing Abbott Sees Continued Demand for SARS-CoV-2 Rapid Tests Despite Expected Decline in Cases Premium The firm more than doubled its COVID-19 testing-related revenues during Q3 compared to a year ago. Around 84 percent of the revenues were for rapid screening tests. Abbott Q3 Diagnostics Revenues Rise 48 Percent on Core Lab, Rapid Diagnostics Sales Growth The firm said its global COVID-19 testing-related sales were $1.9 billion in the third quarter, while its Rapid Diagnostics revenues rose 145 percent year over year. RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests The awards support the development, validation, scale-up, and manufacturing of the tests with the goal of bringing them to market as early as this year. Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate Quidel expects approximately $406.0 million in COVID-19 revenues compared with $375.7 million a year ago. Swab at Home The Washington Post says the White House is to announce a $1 billion purchase of at-home tests for SARS-CoV-2. Apr 21, 2021 Roche Diagnostics Q1 Sales Climb 50 Percent Apr 20, 2021 FDA Issues EUAs for SARS-CoV-2 Tests From Synergy Diagnostic Laboratory, Celltrion Apr 15, 2021 FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies Apr 7, 2021 LumiraDx to Go Public on Nasdaq Through SPAC Mar 24, 2021 DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness Premium Mar 16, 2021 Five Companies Win $6M XPrize Competition to Develop Fast, Cheap COVID-19 Testing Mar 10, 2021 Quidel Guides for Revenues Below Street Estimate, Citing Softening SARS-CoV-2 Test Demand Mar 1, 2021 OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate Feb 22, 2021 FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers Feb 18, 2021 Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates Feb 17, 2021 RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing Premium Feb 9, 2021 Qiagen Reports 38 Percent Q4 Revenue Growth; Beats Analyst Estimates, Prior Guidance Feb 4, 2021 Roche Diagnostics Expanding Manufacturing Capacity, Testing Portfolio in 2021 Premium Breaking News Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East DNA Script Raises $165M in Series C Funding Round SelfDecode Raises Over $1M in Crowdfunding Single-Cell Genomics Study Elucidates Viral, Host Factors of Human Cytomegalovirus The Scan Not Immediately Told The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says. Seems Effective in Kids The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease. Intelligence Warning on Bioeconomy Threats US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports. PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.